Methods for monitoring cancer cell pyroptosis

References

1. 1.↵
   2. Hodi FS,
   3. O’Day SJ,
   4. McDermott DF,
   5. Weber RW,
   6. Sosman JA,
   7. Haanen JB, et al.

   Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363: 711–23.

   OpenUrlCrossRefPubMed
2. 2.↵
   2. Tumeh PC,
   3. Harview CL,
   4. Yearley JH,
   5. Shintaku IP,
   6. Taylor EJ,
   7. Robert L, et al.

   PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014; 515: 568–71.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   2. Chen DS,
   3. Mellman I.

   Elements of cancer immunity and the cancer-immune set point. Nature. 2017; 541: 321–30.

   OpenUrlCrossRefPubMed
4. 4.
   2. Tang H,
   3. Li H,
   4. Sun Z.

   Targeting myeloid-derived suppressor cells for cancer therapy. Cancer Biol Med. 2021; Doi: 10.20892/j.issn.2095-3941.2020.0806.

   OpenUrlAbstract/FREE Full Text
5. 5.
   2. Xu Z,
   3. Huang X.

   Cellular immunotherapy for hematological malignancy: recent progress and future perspectives. Cancer Biol Med. 2021; Doi: 10.20892/j.issn.2095-3941.2020.0801.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   2. Hegde PS,
   3. Chen DS.

   Top 10 challenges in cancer immunotherapy. Immunity. 2020; 52: 17–35.

   OpenUrlCrossRefPubMed
7. 7.↵
   2. Bertheloot D,
   3. Latz E,
   4. Franklin BS.

   Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021; 18: 1106–21.

   OpenUrlCrossRef
8. 8.↵
   2. Hanahan D,
   3. Weinberg RA.

   Hallmarks of cancer: the next generation. Cell. 2011; 144: 646.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   2. Broz P,
   3. Pelegrín P,
   4. Shao F.

   The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020; 20: 143–57.

   OpenUrlCrossRefPubMed
10. 10.↵
    2. Friedlander A.

    Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem. 1986; 261: 7123–6.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    2. Brennan M,
    3. Cookson B.

    Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol. 2000; 38: 31–40.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    2. Cookson BT,
    3. Brennan MA.

    Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9: 113–4.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    2. Boise LH,
    3. Collins CM.

    Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol. 2001; 9: 64–7.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    2. Kayagaki N,
    3. Warming S,
    4. Lamkanfi M,
    5. Vande Walle L,
    6. Louie S,
    7. Dong J, et al.

    Non-canonical inflammasome activation targets caspase-11. Nature. 2011; 479: 117–21.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    2. Shi J,
    3. Zhao Y,
    4. Wang Y,
    5. Gao W,
    6. Ding J,
    7. Li P, et al.

    Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014; 514: 187–92.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    2. Shi J,
    3. Zhao Y,
    4. Wang K,
    5. Shi X,
    6. Wang Y,
    7. Huang H, et al.

    Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526: 660–5.

    OpenUrlCrossRefPubMed
17. 17.↵
    2. Kayagaki N,
    3. Stowe I,
    4. Lee B,
    5. O’Rourke K,
    6. Anderson K,
    7. Warming S, et al.

    Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015; 526: 666–71.

    OpenUrlCrossRefPubMed
18. 18.↵
    2. He W,
    3. Wan H,
    4. Hu L,
    5. Chen P,
    6. Wang X,
    7. Huang Z, et al.

    Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015; 25: 1285–98.

    OpenUrlCrossRefPubMed
19. 19.↵
    2. Liu X,
    3. Zhang Z,
    4. Ruan J,
    5. Pan Y,
    6. Magupalli V,
    7. Wu H, et al.

    Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535: 153–8.

    OpenUrlCrossRefPubMed
20. 20.
    2. Ding J,
    3. Wang K,
    4. Liu W,
    5. She Y,
    6. Sun Q,
    7. Shi J, et al.

    Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016; 535: 111–6.

    OpenUrlCrossRefPubMed
21. 21.↵
    2. Chen X,
    3. He W,
    4. Hu L,
    5. Li J,
    6. Fang Y,
    7. Wang X, et al.

    Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016; 26: 1007–20.

    OpenUrlCrossRefPubMed
22. 22.↵
    2. Aglietti R,
    3. Estevez A,
    4. Gupta A,
    5. Ramirez M,
    6. Liu P,
    7. Kayagaki N, et al.

    GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci U S A. 2016; 113: 7858–63.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    2. Wang Y,
    3. Gao W,
    4. Shi X,
    5. Ding J,
    6. Liu W,
    7. He H, et al.

    Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017; 547: 99–103.

    OpenUrlCrossRefPubMed
24. 24.↵
    2. Wu D,
    3. Wang S,
    4. Yu G,
    5. Chen X.

    Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew Chem Int Ed. 2020; 60: 8018–34.

    OpenUrl
25. 25.↵
    2. Yu P,
    3. Zhang X,
    4. Liu N,
    5. Tang L,
    6. Peng C,
    7. Chen X.

    Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021; 6: 128.

    OpenUrl
26. 26.↵
    2. Wang M,
    3. Jiang S,
    4. Zhang Y,
    5. Li P,
    6. Wang K.

    The multifaceted roles of pyroptotic cell death pathways in cancer. Cancers. 2019; 11: 1313.

    OpenUrl
27. 27.↵
    2. Wang Q,
    3. Wang Y,
    4. Ding J,
    5. Wang C,
    6. Zhou X,
    7. Gao W, et al.

    A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020; 579: 421–6.

    OpenUrlCrossRefPubMed
28. 28.↵
    2. Lamkanfi M,
    3. Dixit VM.

    Mechanisms and functions of inflammasomes. Cell. 2014; 157: 1013–22.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    2. Lugrin J,
    3. Martinon F.

    The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018; 281: 99–114.

    OpenUrlCrossRefPubMed
30. 30.
    2. Miao EA,
    3. Leaf IA,
    4. Treuting PM,
    5. Mao DP,
    6. Dors M,
    7. Sarkar A, et al.

    Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010; 11: 1136–42.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.
    2. Broz P,
    3. Dixit V.

    Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016; 16: 407–20.

    OpenUrlCrossRefPubMed
32. 32.↵
    2. Vanaja S,
    3. Rathinam V,
    4. Fitzgerald K.

    Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol. 2015; 25: 308–15.

    OpenUrlCrossRefPubMed
33. 33.↵
    2. Boucher D,
    3. Monteleone M,
    4. Coll R,
    5. Chen K,
    6. Ross C,
    7. Teo J, et al.

    Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med. 2018; 215: 827–40.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    2. Miao EA,
    3. Mao DP,
    4. Yudkovsky N,
    5. Bonneau R,
    6. Lorang CG,
    7. Warren SE, et al.

    Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A. 2010; 107: 3076–80.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    2. Sborgi L,
    3. Rühl S,
    4. Mulvihill E,
    5. Pipercevic J,
    6. Heilig R,
    7. Stahlberg H, et al.

    GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016; 35: 1766–78.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    2. Yang J,
    3. Liu Z,
    4. Wang C,
    5. Yang R,
    6. Rathkey J,
    7. Pinkard O, et al.

    Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor. Proc Natl Acad Sci U S A. 2018; 115: 6792–7.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    2. Xia S,
    3. Zhang Z,
    4. Magupalli V,
    5. Pablo J,
    6. Dong Y,
    7. Vora S, et al.

    Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021; 593: 607–11.

    OpenUrl
38. 38.↵
    2. Baker PJ,
    3. Boucher D,
    4. Bierschenk D,
    5. Tebartz C,
    6. Whitney PG,
    7. D’Silva DB, et al.

    NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol. 2015; 45: 2918–26.

    OpenUrlCrossRefPubMed
39. 39.↵
    2. Rühl S,
    3. Broz P.

    Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 2015; 45: 2927–36.

    OpenUrlCrossRefPubMed
40. 40.↵
    2. Davis M,
    3. Fairgrieve M,
    4. Den Hartigh A,
    5. Yakovenko O,
    6. Duvvuri B,
    7. Lood C, et al.

    Calpain drives pyroptotic vimentin cleavage, intermediate filament loss, and cell rupture that mediates immunostimulation. Proc Natl Acad Sci U S A. 2019; 116: 5061–70.

    OpenUrlAbstract/FREE Full Text
41. 41.↵
    2. Rühl S,
    3. Shkarina K,
    4. Demarco B,
    5. Heilig R,
    6. Santos J,
    7. Broz P.

    ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362: 956–60.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    2. Yang D,
    3. He Y,
    4. Muñoz-Planillo R,
    5. Liu Q,
    6. Núñez G.

    Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015; 43: 923–32.

    OpenUrlCrossRefPubMed
43. 43.↵
    2. Chen K,
    3. Demarco B,
    4. Broz P.

    Pannexin-1 promotes NLRP3 activation during apoptosis but is dispensable for canonical or noncanonical inflammasome activation. Eur J Immunol. 2020; 50: 170–7.

    OpenUrl
44. 44.↵
    2. Chen K,
    3. Demarco B,
    4. Heilig R,
    5. Shkarina K,
    6. Boettcher A,
    7. Farady C, et al.

    Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019; 38: e101638.
45. 45.↵
    2. Evavold C,
    3. Hafner-Bratkovič I,
    4. Devant P,
    5. D’Andrea J,
    6. Ngwa E,
    7. Boršić E, et al.

    Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell. 2021; 184: 4495–511.

    OpenUrlCrossRef
46. 46.↵
    2. Rogers C,
    3. Fernandes-Alnemri T,
    4. Mayes L,
    5. Alnemri D,
    6. Cingolani G,
    7. Alnemri E.

    Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017; 8: 14128.
47. 47.↵
    2. Orning P,
    3. Weng D,
    4. Starheim K,
    5. Ratner D,
    6. Best Z,
    7. Lee B, et al.

    Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018; 362: 1064–9.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    2. Sarhan J,
    3. Liu BC,
    4. Muendlein HI,
    5. Li P,
    6. Nilson R,
    7. Tang AY, et al.

    Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci U S A. 2018; 115: E10888–97.

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    2. Zheng Z,
    3. Deng W,
    4. Bai Y,
    5. Miao R,
    6. Liu X.

    The lysosomal Rag-Ragulator complex licenses RIPK1– and caspase-8–mediated pyroptosis by yersinia. Science. 2021; 372: eabg0269.
50. 50.↵
    2. Hou J,
    3. Zhao R,
    4. Xia W,
    5. Chang CW,
    6. You Y,
    7. Hsu JM, et al.

    PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020; 22: 1264–75.

    OpenUrl
51. 51.↵
    2. Zhou Z,
    3. He H,
    4. Wang K,
    5. Shi X,
    6. Wang Y,
    7. Su Y, et al.

    Granzyme a from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020; 368: eaaz7548.
52. 52.
    2. Liu Y,
    3. Fang Y,
    4. Chen X,
    5. Wang Z,
    6. Liang X,
    7. Zhang T, et al.

    Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020; 5: eaax7969.
53. 53.↵
    2. Zhang Z,
    3. Zhang Y,
    4. Xia S,
    5. Kong Q,
    6. Li S,
    7. Liu X, et al.

    Gasdermin e suppresses tumour growth by activating anti-tumour immunity. Nature. 2020; 579: 415–20.

    OpenUrlCrossRefPubMed
54. 54.↵
    2. Snyder AG,
    3. Oberst A.

    The antisocial network: cross talk between cell death programs in host defense. Annu Rev Immunol. 2021; 39: 77–101.

    OpenUrl
55. 55.↵
    2. Fink S,
    3. Cookson B.

    Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005; 73: 1907–16.

    OpenUrlFREE Full Text
56. 56.↵
    2. Galluzzi L,
    3. Vitale I,
    4. Aaronson SA,
    5. Abrams JM,
    6. Adam D,
    7. Agostinis P, et al.

    Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018; 25: 486–541.

    OpenUrlCrossRefPubMed
57. 57.↵
    2. Kesavardhana S,
    3. Malireddi RKS,
    4. Kanneganti TD.

    Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020; 38: 567–95.

    OpenUrlCrossRefPubMed
58. 58.↵
    2. Jorgensen I,
    3. Miao EA.

    Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015; 265: 130–42.

    OpenUrlCrossRefPubMed
59. 59.↵
    2. Bergsbaken T,
    3. Cookson BT.

    Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 2007; 3: e161.
60. 60.↵
    2. Tsuchiya K.

    Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity. Int J Mol Sci. 2021; 22: 426.

    OpenUrl
61. 61.↵
    2. Frank D,
    3. Vince J.

    Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019; 26: 99–114.

    OpenUrlCrossRefPubMed
62. 62.↵
    2. Kaiser WJ,
    3. Upton JW,
    4. Long AB,
    5. Livingston-Rosanoff D,
    6. Daley-Bauer LP,
    7. Hakem R, et al.

    RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011; 471: 368–72.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.↵
    2. Oberst A,
    3. Dillon CP,
    4. Weinlich R,
    5. McCormick LL,
    6. Fitzgerald P,
    7. Pop C, et al.

    Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011; 471: 363–7.

    OpenUrlCrossRefPubMedWeb of Science
64. 64.↵
    2. Li Z,
    3. Huang Z,
    4. Zhang H,
    5. Lu J,
    6. Tian Y,
    7. Wei Y, et al.

    P2X7 receptor induces pyroptotic inflammation and cartilage degradation in osteoarthritis via NF-κB/NLRP3 crosstalk. Oxid Med Cell Longev. 2021; 2021: 8868361.
65. 65.↵
    2. Xie W,
    3. Ding J,
    4. Xie X,
    5. Yang X,
    6. Wu X,
    7. Chen Z, et al.

    Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflamm Res. 2020; 69: 683–96.

    OpenUrlCrossRef
66. 66.↵
    2. Yang W,
    3. Liu S,
    4. Li Y,
    5. Wang Y,
    6. Deng Y,
    7. Sun W, et al.

    Pyridoxine induces monocyte-macrophages death as specific treatment of acute myeloid leukemia. Cancer Lett. 2020; 492: 96–105.

    OpenUrl
67. 67.↵
    2. Hu JJ,
    3. Liu X,
    4. Xia S,
    5. Zhang Z,
    6. Zhang Y,
    7. Zhao J, et al.

    FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020; 21: 736–45.

    OpenUrlCrossRefPubMed
68. 68.↵
    2. Xia S,
    3. Ruan J,
    4. Wu H.

    Monitoring gasdermin pore formation in vitro. Methods Enzymol. 2019; 625: 95–107.

    OpenUrl
69. 69.↵
    2. Mulvihill E,
    3. Sborgi L,
    4. Mari S,
    5. Pfreundschuh M,
    6. Hiller S,
    7. Müller D.

    Mechanism of membrane pore formation by human gasdermin-D. EMBO J. 2018; 37: e98321.
70. 70.↵
    2. Liu Y,
    3. Zhang T,
    4. Zhou Y,
    5. Li J,
    6. Liang X,
    7. Zhou N, et al.

    Visualization of perforin/gasdermin/complement-formed pores in real cell membranes using atomic force microscopy. Cell Mol Immunol. 2019; 16: 611–20.

    OpenUrlCrossRefPubMed
71. 71.↵
    2. Liu L,
    3. Sha R,
    4. Yang L,
    5. Zhao X,
    6. Zhu Y,
    7. Gao J, et al.

    Impact of morphology on iron oxide nanoparticles-induced inflammasome activation in macrophages. ACS Appl Mater Inter. 2018; 10: 41197–206.

    OpenUrl
72. 72.↵
    2. Du Q,
    3. Ge D,
    4. Mirshafiee V,
    5. Chen C,
    6. Li M,
    7. Xue C, et al.

    Assessment of neurotoxicity induced by different-sized stober silica nanoparticles: induction of pyroptosis in microglia. Nanoscale. 2019; 11: 12965–72.

    OpenUrl
73. 73.↵
    2. Duan WR,
    3. Garner DS,
    4. Williams SD,
    5. Funckes-Shippy CL,
    6. Spath IS,
    7. Blomme EA.

    Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol. 2003; 199: 221–8.

    OpenUrlCrossRefPubMedWeb of Science
74. 74.↵
    2. Jiang L,
    3. Poon I.

    Methods for monitoring the progression of cell death, cell disassembly and cell clearance. Apoptosis. 2019; 24: 208–20.

    OpenUrl
75. 75.↵
    2. Volchuk A,
    3. Ye A,
    4. Chi L,
    5. Steinberg BE,
    6. Goldenberg NM.

    Indirect regulation of HMGB1 release by gasdermin D. Nat Commun. 2020; 11: 4561.

    OpenUrlCrossRef
76. 76.↵
    2. Russo AJ,
    3. Vasudevan SO,
    4. Mendez-Huergo SP,
    5. Kumari P,
    6. Menoret A,
    7. Duduskar S, et al.

    Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin. Nat Immunol. 2021; 22: 154–65.

    OpenUrl
77. 77.↵
    2. Mirshafiee V,
    3. Sun B,
    4. Chang C,
    5. Liao Y,
    6. Jiang W,
    7. Jiang J, et al.

    Toxicological profiling of metal oxide nanoparticles in liver context reveals pyroptosis in Kupffer cells and macrophages versus apoptosis in hepatocytes. ACS Nano. 2018; 12: 3836–52.

    OpenUrl
78. 78.↵
    2. Garrod KR,
    3. Moreau HD,
    4. Garcia Z,
    5. Lemaitre F,
    6. Bouvier I,
    7. Albert ML, et al.

    Dissecting T cell contraction in vivo using a genetically encoded reporter of apoptosis. Cell Rep. 2012; 2: 1438–47.

    OpenUrlCrossRefPubMed
79. 79.↵
    2. Posson DJ,
    3. Rusinova R,
    4. Andersen OS,
    5. Nimigean CM.

    Stopped-flow fluorometric ion flux assay for ligand-gated ion channel studies. Methods Mol Biol. 2018; 1684: 223–35.

    OpenUrlCrossRef
80. 80.↵
    2. Zhang C,
    3. Li C,
    4. Wang Y,
    5. Xu L,
    6. He X,
    7. Zeng Q, et al.

    Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation. Apoptosis. 2019; 24: 312–25.

    OpenUrlCrossRef
81. 81.↵
    2. Wang Y,
    3. Yin B,
    4. Li D,
    5. Wang G,
    6. Han X,
    7. Sun X.

    GSDME mediates caspase-3-dependent pyroptosis in gastric cancer. Biochem Biophys Res Commun. 2018; 495: 1418–25.

    OpenUrlCrossRef
82. 82.↵
    2. Galluzzi L,
    3. Kroemer G.

    Secondary necrosis: accidental no more. Trends Cancer. 2017; 3: 1–2.

    OpenUrl
83. 83.↵
    2. Fink SL,
    3. Cookson BT.

    Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 2006; 8: 1812–25.

    OpenUrlCrossRefPubMedWeb of Science
84. 84.↵
    2. Ploetz E,
    3. Zimpel A,
    4. Cauda V,
    5. Bauer D,
    6. Lamb D,
    7. Haisch C, et al.

    Metal-organic framework nanoparticles induce pyroptosis in cells controlled by the extracellular PH. Adv Mater. 2020; 32: e1907267.
85. 85.↵
    2. Bedoui S,
    3. Herold M,
    4. Strasser A.

    Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020; 21: 678–95.

    OpenUrl
86. 86.↵
    2. Lu Y,
    3. Xu S,
    4. Chen H,
    5. He M,
    6. Deng Y,
    7. Cao Z, et al.

    CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials. 2016; 90: 27–39.

    OpenUrl
87. 87.↵
    2. Wang D,
    3. Zheng J,
    4. Hu Q,
    5. Zhao C,
    6. Chen Q,
    7. Shi P, et al.

    Magnesium protects against sepsis by blocking gasdermin D N-terminal-induced pyroptosis. Cell Death Differ. 2020; 27: 466–81.

    OpenUrl
88. 88.↵
    2. Zhao P,
    3. Wang M,
    4. Chen M,
    5. Chen Z,
    6. Peng X,
    7. Zhou F, et al.

    Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials. 2020; 254: 120142.
89. 89.↵
    2. Wang K,
    3. Sun Q,
    4. Zhong X,
    5. Zeng M,
    6. Zeng H,
    7. Shi X, et al.

    Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell. 2020; 180: 941–55 e20.

    OpenUrlCrossRefPubMed
90. 90.↵
    2. Vanden Berghe T,
    3. Grootjans S,
    4. Goossens V,
    5. Dondelinger Y,
    6. Krysko DV,
    7. Takahashi N, et al.

    Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods. 2013; 61: 117–29.

    OpenUrlCrossRefPubMed
91. 91.↵
    2. Muendlein H,
    3. Jetton D,
    4. Connolly W,
    5. Eidell K,
    6. Magri Z,
    7. Smirnova I, et al.

    cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation. Science. 2020; 367: 1379–84.

    OpenUrlAbstract/FREE Full Text
92. 92.↵
    2. Ruan J,
    3. Wang S,
    4. Wang J.

    Mechanism and regulation of pyroptosis-mediated in cancer cell death. Chem Biol Interact. 2020; 323: 109052.
93. 93.↵
    2. Galon J,
    3. Bruni D.

    Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 2019; 18: 197–218.

    OpenUrlPubMed
94. 94.↵
    2. Liu Y,
    3. Sun Z.

    Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021; 11: 5365–86.

    OpenUrl
95. 95.↵
    2. Karki R,
    3. Sharma B,
    4. Tuladhar S,
    5. Williams E,
    6. Zalduondo L,
    7. Samir P, et al.

    Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021; 184: 149–68.e17.

    OpenUrlCrossRefPubMed
96. 96.↵
    2. Moossavi M,
    3. Parsamanesh N,
    4. Bahrami A,
    5. Atkin SL,
    6. Sahebkar A.

    Role of the NLRP3 inflammasome in cancer. Mol Cancer. 2018; 17: 158.

    OpenUrlCrossRefPubMed
97. 97.↵
    2. Humphries F,
    3. Shmuel-Galia L,
    4. Ketelut-Carneiro N,
    5. Li S,
    6. Wang B,
    7. Nemmara VV, et al.

    Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020; 369: 1633–7.

    OpenUrlAbstract/FREE Full Text
98. 98.↵
    2. Alvero AB,
    3. Mor GG.

    Detection of cell death mechanisms: methods and protocols. Methods Mol Biol. 2021; 2255: 149–57.

    OpenUrl
99. 99.↵
    2. Mesa K,
    3. Rompolas P,
    4. Zito G,
    5. Myung P,
    6. Sun T,
    7. Brown S, et al.

    Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool. Nature. 2015; 522: 94–7.

    OpenUrlCrossRefPubMed
100. 100.↵
     2. Mayer C,
     3. Gazumyan A,
     4. Kara E,
     5. Gitlin A,
     6. Golijanin J,
     7. Viant C, et al.

     The microanatomic segregation of selection by apoptosis in the germinal center. Science. 2017; 358: eaao2602.
101. 101.↵
     2. Li Q,
     3. Shi N,
     4. Cai C,
     5. Zhang M,
     6. He J,
     7. Tan Y, et al.

     The role of mitochondria in pyroptosis. Front Cell Dev Biol. 2020; 8: 630771.